{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T04:36:35Z","timestamp":1767414995568,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s12928-022-00841-7","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T11:05:51Z","timestamp":1643799951000},"page":"660-669","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-term outcomes of the modest stent expansion strategy for the culprit lesion of acute myocardial infarction"],"prefix":"10.1007","volume":"37","author":[{"given":"Yusuke","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3566-0394","authenticated-orcid":false,"given":"Kenichi","family":"Sakakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousuke","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Seguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takunori","family":"Tsukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Jinnouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"841_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1620\/tjem.225.13","volume":"225","author":"O Karakaya","year":"2011","unstructured":"Karakaya O, Ko\u00e7er A, Esen AM, et al. Impaired cerebral circulation in patients with slow coronary flow. Tohoku J Exp Med. 2011;225:13\u20136.","journal-title":"Tohoku J Exp Med"},{"key":"841_CR2","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/S0735-1097(00)00865-2","volume":"36","author":"I Morishima","year":"2000","unstructured":"Morishima I, Sone T, Okumura K, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol. 2000;36:1202\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"841_CR3","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1002\/clc.20634","volume":"33","author":"L Dong-bao","year":"2010","unstructured":"Dong-bao L, Qi H, Zhi L, et al. Predictors and long-term prognosis of angiographic slow\/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction. Clin Cardiol. 2010;33:E7-12.","journal-title":"Clin Cardiol"},{"key":"841_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ijcard.2010.10.120","volume":"146","author":"N Cutri","year":"2011","unstructured":"Cutri N, Zeitz C, Kucia AM, Beltrame JF. ST\/T wave changes during acute coronary syndrome presentation in patients with the coronary slow flow phenomenon. Int J Cardiol. 2011;146:457\u20138.","journal-title":"Int J Cardiol"},{"key":"841_CR5","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/clc.20266","volume":"31","author":"S Saya","year":"2008","unstructured":"Saya S, Hennebry TA, Lozano P, et al. Coronary slow flow phenomenon and risk for sudden cardiac death due to ventricular arrhythmias: a case report and review of literature. Clin Cardiol. 2008;31:352\u20135.","journal-title":"Clin Cardiol"},{"key":"841_CR6","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.12998\/wjcc.v7.i15.2013","volume":"7","author":"MJ Zhang","year":"2019","unstructured":"Zhang MJ, Liu X, Liu LH, et al. Correlation between intracoronary thrombus components and coronary blood flow after percutaneous coronary intervention for acute myocardial infarction at different onset time. World J Clin Cases. 2019;7:2013\u201321.","journal-title":"World J Clin Cases"},{"key":"841_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00380-017-1050-z","volume":"33","author":"Y Watanabe","year":"2018","unstructured":"Watanabe Y, Sakakura K, Taniguchi Y, et al. Determinants of slow flow following stent implantation in intravascular ultrasound-guided primary percutaneous coronary intervention. Heart Vessels. 2018;33:226\u201338.","journal-title":"Heart Vessels"},{"key":"841_CR8","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1536\/ihj.18-050","volume":"59","author":"Y Watanabe","year":"2018","unstructured":"Watanabe Y, Sakakura K, Taniguchi Y, et al. Determinants of slow flow in percutaneous coronary intervention to the culprit lesion of non-ST elevation myocardial infarction. Int Heart J. 2018;59:1237\u201345.","journal-title":"Int Heart J"},{"key":"841_CR9","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1161\/01.CIR.86.6.1827","volume":"86","author":"RE Kuntz","year":"1992","unstructured":"Kuntz RE, Safian RD, Carrozza JP, et al. The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting. Circulation. 1992;86:1827\u201335.","journal-title":"Circulation"},{"key":"841_CR10","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1053\/euhj.1998.1012","volume":"19","author":"P de Jaegere","year":"1998","unstructured":"de Jaegere P, Mudra H, Figulla H, et al. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study). Eur Heart J. 1998;19:1214\u201323.","journal-title":"Eur Heart J"},{"key":"841_CR11","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1161\/01.CIR.91.6.1676","volume":"91","author":"A Colombo","year":"1995","unstructured":"Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676\u201388.","journal-title":"Circulation"},{"key":"841_CR12","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/j.jacc.2005.12.072","volume":"47","author":"RL McNamara","year":"2006","unstructured":"McNamara RL, Wang Y, Herrin J, et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2006;47:2180\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"841_CR13","doi-asserted-by":"crossref","unstructured":"TIMI study group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985;312:932\u20136.","DOI":"10.1056\/NEJM198504043121437"},{"key":"841_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jjcc.2018.08.006","volume":"73","author":"EH Choo","year":"2019","unstructured":"Choo EH, Koh YS, Seo SM, et al. Comparison of successful percutaneous coronary intervention versus optimal medical therapy in patients with coronary chronic total occlusion. J Cardiol. 2019;73:156\u201362.","journal-title":"J Cardiol"},{"key":"841_CR15","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/j.jcin.2019.05.054","volume":"12","author":"A Jeremias","year":"2019","unstructured":"Jeremias A, Davies JE, Maehara A, et al. Blinded physiological assessment of residual ischemia after successful angiographic percutaneous coronary intervention: the DEFINE PCI study. JACC Cardiovasc Interv. 2019;12:1991\u20132001.","journal-title":"JACC Cardiovasc Interv"},{"key":"841_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12928-020-00669-z","volume":"35","author":"M Sawano","year":"2020","unstructured":"Sawano M, Yamaji K, Kohsaka S, et al. Contemporary use and trends in percutaneous coronary intervention in Japan: an outline of the J-PCI registry. Cardiovasc Interv Ther. 2020;35:218\u201326.","journal-title":"Cardiovasc Interv Ther"},{"key":"841_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","volume":"40","author":"K Thygesen","year":"2019","unstructured":"Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40:237\u201369.","journal-title":"Eur Heart J"},{"key":"841_CR18","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1536\/ihj.16-170","volume":"57","author":"Y Watanabe","year":"2016","unstructured":"Watanabe Y, Sakakura K, Taniguchi Y, et al. Determinants of in-hospital death in acute myocardial infarction with triple vessel disease. Int Heart J. 2016;57:697\u2013704.","journal-title":"Int Heart J"},{"key":"841_CR19","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"841_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1177\/0003319715605977","volume":"67","author":"T Celik","year":"2016","unstructured":"Celik T, Balta S, Ozturk C, et al. Predictors of no-reflow phenomenon in young patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2016;67:683\u20139.","journal-title":"Angiology"},{"key":"841_CR21","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","volume":"93","author":"CM Gibson","year":"1996","unstructured":"Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93:879\u201388.","journal-title":"Circulation"},{"key":"841_CR22","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/S0735-1097(01)01175-5","volume":"37","author":"GS Mintz","year":"2001","unstructured":"Mintz GS, Nissen SE, Anderson WD, et al. American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American college of cardiology task force on clinical expert consensus documents. J Am Coll Cardiol. 2001;37:1478\u201392.","journal-title":"J Am Coll Cardiol"},{"key":"841_CR23","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1001\/jamainternmed.2018.0514","volume":"178","author":"E Cenko","year":"2018","unstructured":"Cenko E, Yoon J, Kedev S, et al. Sex differences in outcomes after STEMI: effect modification by treatment strategy and age. JAMA Intern Med. 2018;178:632\u20139.","journal-title":"JAMA Intern Med"},{"key":"841_CR24","doi-asserted-by":"publisher","first-page":"e013880","DOI":"10.1161\/JAHA.119.013880","volume":"9","author":"A Shehab","year":"2020","unstructured":"Shehab A, Bhagavathula AS, Alhabib KF, et al. Age-related sex differences in clinical presentation, management, and outcomes in ST-segment-elevation myocardial infarction: pooled analysis of 15 532 patients From 7 Arabian Gulf registries. J Am Heart Assoc. 2020;9:e013880.","journal-title":"J Am Heart Assoc"},{"key":"841_CR25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.arcmed.2019.01.005","volume":"49","author":"G Borrayo-S\u00e1nchez","year":"2018","unstructured":"Borrayo-S\u00e1nchez G, Rosas-Peralta M, Ram\u00edrez-Arias E, et al. STEMI and NSTEMI: real-world study in Mexico (RENASCA). Arch Med Res. 2018;49:609\u201319.","journal-title":"Arch Med Res"},{"key":"841_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.carrev.2017.05.010","volume":"18","author":"LO Jensen","year":"2017","unstructured":"Jensen LO, Vikman S, Antonsen L, et al. Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS). Cardiovasc Revasc Med. 2017;18:577\u201382.","journal-title":"Cardiovasc Revasc Med"},{"key":"841_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jacc.2004.04.036","volume":"44","author":"H Sato","year":"2004","unstructured":"Sato H, Iida H, Tanaka A, et al. The decrease of plaque volume during percutaneous coronary intervention has a negative impact on coronary flow in acute myocardial infarction: a major role of percutaneous coronary intervention-induced embolization. J Am Coll Cardiol. 2004;44:300\u20134.","journal-title":"J Am Coll Cardiol"},{"key":"841_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0002-9149(96)00486-9","volume":"78","author":"I Moussa","year":"1996","unstructured":"Moussa I, Di Mario C, Di Francesco L, et al. Subacute stent thrombosis and the anticoagulation controversy: changes in drug therapy, operator technique, and the impact of intravascular ultrasound. Am J Cardiol. 1996;78:13\u20137.","journal-title":"Am J Cardiol"},{"key":"841_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4244\/V5I3A55","volume":"5","author":"S Rathore","year":"2009","unstructured":"Rathore S, Terashima M, Katoh O, et al. Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients. EuroIntervention. 2009;5:349\u201354.","journal-title":"EuroIntervention"},{"key":"841_CR30","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1093\/eurheartj\/eht241","volume":"34","author":"M Nakano","year":"2013","unstructured":"Nakano M, Otsuka F, Yahagi K, et al. Human autopsy study of drug-eluting stents restenosis: histomorphological predictors and neointimal characteristics. Eur Heart J. 2013;34:3304\u201313.","journal-title":"Eur Heart J"},{"key":"841_CR31","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1016\/j.jacc.2014.02.607","volume":"63","author":"M Nakano","year":"2014","unstructured":"Nakano M, Yahagi K, Otsuka F, et al. Causes of early stent thrombosis in patients presenting with acute coronary syndrome: an ex vivo human autopsy study. J Am Coll Cardiol. 2014;63:2510\u201320.","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-022-00841-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-022-00841-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-022-00841-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T07:16:25Z","timestamp":1663139785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-022-00841-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["841"],"URL":"https:\/\/doi.org\/10.1007\/s12928-022-00841-7","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"type":"print","value":"1868-4300"},{"type":"electronic","value":"1868-4297"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"9 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Sakakura has received speaking honoraria from Abbott Vascular, Boston Scientific, Medtronic Cardiovascular, Terumo, OrbusNeich, Japan Lifeline, Kaneka, and NIPRO; he has served as a proctor for Rotablator for Boston Scientific, and he has served as a consultant for Abbott Vascular and Boston Scientific. Prof. Fujita has served as a consultant for Mehergen Group Holdings, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}